The Nordic Conference | COPENHAGEN
The Neuro-Exposome: Mapping the Gut-Brain Axis in Cognitive Decline, Mood & Spectrum Disorders 
20-22 November 2026

*Super Early Bird pricing available until 1 May 2026*

Join us for a comprehensive educational event designed for practitioners who are ready to advance their expertise in genetic and functional testing with a focus on the exposome, its relationship with the gut-brain axis and impact on neuro-pathology - from development to cognitive decline.

The Exposome - the totality of environmental exposures across the lifespan - is now recognised as a primary modulator of brain function and mental health, often mediated through the gut-brain axis. Influencing the gut-brain axis, factors like chronic inflammation, insulin resistance and xenobiotic exposure drive the neuro-pathology seen in cognitive decline, spectrum and mood disorders. Translating the complexity of these interactions into better patient care is the focus of this conference. Through practical case studies, practitioners will learn to use genetic and functional testing to gain deeper insights that support highly personalised treatment plans.

Learn how, using clinical case studies, to interpret and incorporate an array of functional and genetic laboratory tests including:
DNA Mind | DNA Gut | DNA Hormones | DNA Core | Growbaby | Organic Acids & Metabolomics | Neurotransmitter Profiles | MycoTOX | TOXDetect | DUTCH | GI-MAP | TinyHealth | Cardiometabolic & Fatty Acid Profiles.

More information about the speakers and programme will be announced here very soon but we hope that by sharing the dates, this exciting event can be added to your 2026 plans and you are able join us in November.

Practical:
Dates and Times: 20-22 November 2026 | 09:00-18:00 (TBC)
Location: Copenhagen (Venue TBC)

If you have any questions, please email events@nordicgroup.eu